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Abstract Cholesterol enrichment of rat liver mitochondria
(CHM) impairs atractyloside-induced mitochondrial permeabil-
ity transition (MPT) due to decreased membrane £uidity. In this
study we addressed the e¡ect of cholesterol enrichment on MPT
induced by reactive oxygen species (ROS). Superoxide anion
generated by xanthine plus xanthine oxidase triggered mito-
chondrial swelling and cytochrome c release in CHM, which
was prevented by butylated hydroxytoluene, an anti-voltage-de-
pendent anion channel antibody, or cyclosporin A. Furthermore,
hydrogen peroxide generated by the combination of ganglioside
GD3 and mitochondrial GSH depletion elicited mitochondrial
swelling and release of cytochrome c, Smac/Diablo and apopto-
sis-inducing factor in control mitochondria and CHM. Thus,
ROS induce MPT and apoptosome activation regardless of de-
creased mitochondrial membrane dynamics due to cholesterol
enrichment.
- 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
The mitochondrial permeability transition (MPT), a process
characterized by mitochondrial swelling, uncoupling and inner
membrane permeabilization to small solutes, provides a mech-
anism for the mitochondrial regulation of cell death [1^3].
During this process several proteins that normally reside in
the intermembrane and intracristal space are released into the
cytosol; once there they can either assist in apoptosome as-
sembly or disable inhibitor of apoptosis proteins, thus pro-
moting cell death [4,5]. Apoptosis-inducing factor (AIF), an-
other protein released during mitochondrial permeabilization,
induces the characteristic morphological changes of apoptosis
in a caspase-independent manner [6]. Although MPT consti-
tutes a gateway for the release of these specialized mitochon-
drial proteins, they can also escape mitochondria in a MPT-
independent fashion involving the selective permeabilization
of the outer mitochondrial membrane without disruption of
the inner membrane [7^10].
MPT is a multiprotein complex whose molecular composi-
tion and regulation is not entirely understood. A current mod-
el indicates the involvement and interaction of proteins at
speci¢c sites where the inner and outer mitochondrial mem-
branes contact [11,12]. MPT can be regulated by several fac-
tors including Ca2þ, ADP levels, matrix pH, v8m, mitochon-
drial energy status and lipid peroxidation [13^18]. In addition
to these factors, reactive oxygen species (ROS) also regulate
MPT by targeting speci¢c thiol residues of certain MPT com-
ponents, e.g. adenine nucleotide translocator (ANT) [19,20].
Furthermore, superoxide anion was shown to induce cyto-
chrome c (cyt c) release by a voltage-dependent anion channel
(VDAC)-dependent permeabilization of the outer mitochon-
drial membrane [21].
Glycosphingolipids regulate many cellular functions such as
cell adhesion and signal transduction [22,23]. Particularly,
ganglioside GD3 (GD3), a sialic acid-containing glycosphin-
golipid, has been identi¢ed as a lipid death e¡ector [24]. GD3
interacts with mitochondria in intact cells in response to ap-
optotic stimuli and elicits a burst of ROS from the mitochon-
drial respiratory chain contributing to the release of proapop-
totic proteins and apoptosome activation [25^28].
Recent studies have shown that cholesterol enrichment of
isolated rat liver mitochondria (CHM) impaired the ANT-
mediated MPT and subsequent release of mitochondrial pro-
apoptotic proteins due to decreased membrane £uidity [29].
Thus, in the present study, we addressed the e¡ect of choles-
terol enrichment on ROS-induced MPT, monitored as mito-
chondrial swelling and subsequent release of proapoptotic
proteins and apoptosome activation in a cell-free system.
2. Materials and methods
2.1. Reagents and antibodies
Atractyloside (ATR), cyclosporin A (CSA), cholesterol, o-phthalal-
dehyde, phenylmethylsulfonyl £uoride, CHAPS, pepstatin A, leupep-
tin, aprotinin, N-acetyl-leucyl-leucyl-norleucine, xanthine, xanthine
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oxidase and butylated hydroxytoluene (BHT) were purchased from
Sigma (St. Louis, MO, USA). 4,4P-Diisothiocyanatostilbene-2,2P-di-
sulfonic acid (DIDS) was from Molecular Probes (Eugene, OR,
USA). GD3 was from Matreya (Pleasant Gap, PA, USA, 99% purity
by thin layer chromatography). Carboxy-2P,7P-dichlorodihydro£uores-
cein diacetate methyl ester (carboxy-H2DCFDA), dihydroethidium
and anti-cytochrome oxidase subunit II were obtained from Molec-
ular Probes. Anti-Smac/Diablo antibody was purchased from Calbio-
chem and anti-cyt c antibody (clone 7H8.2C12) from PharMingen
(San Diego, CA, USA). Rabbit antiserum, anti-AIF and anti-
VDAC antibody, Ab#25, were generous gifts from G. Kroemer
(Centre National de la Recherche Scienti¢que, Villejuif, France) and
Dr. Y. Tsujimoto (Osaka University Graduate School of Medicine,
Osaka, Japan), respectively.
2.2. Mitochondrial preparation and cholesterol loading
Rat liver mitochondria were isolated from liver homogenates by
di¡erential centrifugation or rapid centrifugation through a Percoll
density gradient as described in detail previously [30]. Enrichment
and recovery of mitochondria were ascertained by the speci¢c activity
of succinic dehydrogenase and functional integrity assessed as the
ADP-stimulated oxygen consumption using a Clark oxygen electrode
with succinate as substrate. Mitochondrial cholesterol loading using a
cholesterol^albumin complex and cholesterol determination were per-
formed as detailed previously [29].
2.3. Depletion of mitochondrial GSH
(R,S)-3-Hydroxy-4-pentenoate (HP) was synthesized as described
previously [31] and used to deplete mitochondrial reduced glutathione
(mGSH) levels [32]. GSH was measured from mitochondria after tri-
chloroacetic acid precipitation by high performance liquid chromatog-
raphy as described [32].
2.4. ROS determination
Mitochondrial suspensions were exposed to xanthine plus xanthine
oxidase (X+XO) or GD3 with or without preincubation with HP in
the presence of CM-H2DCFDA (1 WM, 505 nm excitation and 529
mm emission) or dihydroethidium (5 WM, 480 nm excitation and 620
nm emission) and £uorescence was measured in a £uorimeter as de-
scribed previously [32].
2.5. Measurement of MPT
Large-amplitude swelling was measured spectrophotometrically by
recording absorbance at 540 nm (A540nm). Isolated rat liver mitochon-
dria (1 mg/ml) were suspended in a bu¡er consisting of 200 mM
sucrose, 10 mM Tris-MOPS, 5 mM succinate, 1 mM potassium phos-
phate, 2 WM rotenone, 1 Wg/ml oligomycin, 10 WM EGTA, pH 7.4 at
25‡C as described before [29]. A540nm was registered in control mito-
chondria or CHM after addition of ATR (100 WM), X+XO (0.1 mM
and 20 U/ml, respectively) or GD3 (10 WM) with or without CSA
(5 WM).
2.6. Western blot analysis of cyt c, Smac/Diablo and AIF
Mitochondrial supernatants and pellets were collected by centrifu-
gation at 10 000Ug for 5 min at 4‡C. 20^25 Wg proteins were sepa-
rated by sodium dodecyl sulfate^polyacrylamide gel electrophoresis
(15% gel) and transferred to nitrocellulose ¢lters. Blots were probed
with anti-cyt c (mouse monoclonal antibody; clone 7H8.2C12, dilu-
tion 1:2000), anti-AIF (rabbit antiserum, dilution 1:2000) and anti-
Smac/Diablo (rabbit polyclonal antibody, dilution 1:1000) and visu-
alized with horseradish peroxidase-coupled secondary antibodies and
ECL developing kit (Amersham Pharmacia Biotech, Rainham, UK).
Parallel aliquots were analyzed by immunoblotting for the release of
cytochrome oxidase using monoclonal antibody anti-cytochrome oxi-
dase subunit II to con¢rm the speci¢city of mitochondrial protein
release. In some cases mitochondria were treated with CSA (5 WM),
BHT (50 WM), Ab#25 or control IgG antibody (0.5 Wg/ml) and DIDS
(100 WM) to assess their e¡ect on ROS generation, MPT or the release
of mitochondrial proteins induced by X+XO or GD3 (with or without
mGSH depletion by HP).
2.7. Statistical analyses
Statistical analyses for comparison of mean values for multiple
comparisons between mitochondrial preparations were made by
one-way analysis of variance followed by Fisher’s test.
3. Results and discussion
3.1. Superoxide anion induces mitochondrial swelling and
release of cyt c independently of cholesterol content
MPT can be regulated by a number of factors including
reactive oxygen and nitrogen species [19,20]. Recent observa-
tions in rat liver mitochondria have shown that cholesterol
deposition in mitochondrial membranes impaired the ability
of ATR to induce MPT and the release of apoptogenic pro-
teins [29]. Thus, we tested the e¡ect of cholesterol on the
regulation of MPT and release of intermembrane proteins
caused by ROS overgeneration. Exposure of rat liver mito-
chondria to a cholesterol^albumin complex resulted in a sig-
ni¢cant cholesterol deposition (4.3 U 0.5 vs. 10.4U 1.2 Wg cho-
lesterol/mg protein in control mitochondria and CHM,
respectively) compared to mitochondria incubated with albu-
min or cholesterol separately as described previously [29]. Iso-
lated mitochondria with or without cholesterol loading were
exposed to a superoxide anion-generating system, X+XO, ex-
amining changes in A540nm and release of cyt c. The generation
of ROS by X+XO was bimodal and similar in control mito-
chondria or CHM, with a three- to four-fold higher level of
Fig. 1. E¡ect of Oc32 on mitochondrial swelling. Control mitochon-
dria and CHM (1 mg/ml) were incubated with X+XO to examine
the time-dependent increase of dihydroethidium and DCF £uores-
cence (a). Changes in absorbance at 540 nm over time in response
to X+XO (b) were determined in control mitochondria or CHM
with or without incubation with CSA or BHT as indicated in Sec-
tion 2. Solid and broken lines in panel a represent the changes in
control mitochondria and CHM, respectively. Data are the meanU
S.D. of four individual experiments. *P6 0.05 vs. control without
X+XO.
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superoxide anion (determined as dihydroethidium £uores-
cence) with respect to control generated within the ¢rst 5^15
min of X+XO addition. However, while the level of super-
oxide anion decreased by 45 min, the levels of peroxides (de-
termined as DCF £uorescence) increased above control by 30
min of incubation (Fig. 1a). Next, we determined the impact
of ROS generated by X+XO on MPT. As seen the magnitude
of swelling determined by loss of A540nm caused by X+XO was
similar in both control mitochondria and CHM (Fig. 1b). The
e¡ect of X+XO was accompanied by a comparable release of
cyt c in both control mitochondria and CHM (Fig. 2a,b). This
process was speci¢c for cyt c as ascertained from the absence
of cytochrome oxidase in the supernatant of mitochondrial
suspensions (Fig. 2). As expected, cholesterol enrichment de-
creased mitochondrial membrane £uidity monitored from
the £uorescence anisotropy of 1,6-diphenyl-1,3,5-hexatriene
and trimethylammonium 1,6-diphenyl-1,3,5-hexatriene (not
shown) in agreement with recent observations [29]. Further-
more, CSA blocked X+XO-induced mitochondrial swelling
(Fig. 1b) and cyt c release (Fig. 2a,b) to an equal extent in
control mitochondria and CHM (Figs. 1b and 2).
Prior studies indicated that VDAC played a key role in the
permeabilization of the mitochondrial outer membrane and
subsequent release of cyt c induced by superoxide anion
[21]. Thus, we tested whether VDAC was involved in our
current observations with X+XO. Pretreatment of mitochon-
dria with an antibody that interferes with the function of
VDAC, Ab#25, characterized previously [33], blocked the
cyt c release induced by X+XO (Fig. 1b); a control IgG anti-
body, however, had no e¡ect (not shown). Similar results on
the release of cyt c by X+XO were observed when mitochon-
dria were treated with the VDAC blocker DIDS, in agreement
with previous ¢ndings [21,34]. DIDS, however, did not inter-
fere with the generation of ROS by X+XO, further document-
ing that its e¡ect was mediated by targeting VDAC (not
shown). Moreover, the inhibitory e¡ect of the antioxidant
BHT in X+XO-induced cyt c release (Fig. 2) and mitochon-
drial swelling (Fig. 1b) con¢rmed that the e¡ect of X+XO was
mediated by ROS production.
Thus, these data provide evidence that X+XO induces both
mitochondrial swelling and cyt c release regardless of the cho-
lesterol deposition and hence of decreased membrane £uidity
and contrast with recent ¢ndings showing the dependence of
ANT on appropriate mitochondrial membrane £uidity [29].
Some aspects, however, from our ¢ndings are in agreement
with those of Madesh and Hajnoczky [21], namely, the in-
volvement of VDAC in the permeabilization of mitochondria
by X+XO as ascertained from the inhibitory e¡ect of the
speci¢c anti-VDAC antibody used (Ab#25) both in isolated
rat liver mitochondria (our present case) and in permeabilized
HepG2 cells [21]. Moreover, DIDS, an anion inhibitor, mim-
icked the e¡ect of the VDAC antibody #25. Prior studies have
shown that DIDS as well as dicyclohexylcarbodiimide, a car-
boxyl-modifying agent known to bind speci¢cally to mito-
chondrial VDAC [35,36], abolished the channel activity of
VDAC reconstituted in planar lipid bilayers [34,37]. However,
our ¢ndings as opposed to those of Madesh and Hajnoczky
show that CSA prevents X+XO-induced A540nm loss and re-
lease of cyt c. Di¡erences in mitochondria from rat liver vs.
HepG2 cells or in the fate and/or disposition of superoxide
anion formed by X+XO between isolated mitochondria, as in
the present study, compared to permeabilized HepG2 cells, in
which the presence of subcellular organelles may limit the
impact of superoxide anion on mitochondria, may account
for this discrepancy. In addition, although X+XO-induced
superoxide anion may target VDAC in the outer membrane
[21], however, since CSA, in cases where it prevents MPT,
functions by targeting cyclophilin D, an inner mitochondrial
membrane protein (reviewed in [11]), it may be conceivable
that X+XO-induced MPT may involve the participation of
VDAC- and CSA-sensitive inner membrane MPT compo-
nents.
3.2. GSH depletion and GD3 cooperate to induce MPT
regardless of cholesterol deposition
To further verify the sensitivity of CHM to MPT induced
upon ROS generation, we used GD3, a glycosphingolipid de-
scribed previously to cause a burst of ROS from mitochondria
[26,38]. Moreover, since the fate of mitochondrial ROS, par-
ticularly the disposition of hydrogen peroxide, is determined
by the level of mGSH [24,39], we examined the in£uence of
cholesterol loading on MPT induced by GD3 with or without
mGSH depletion. Control mitochondria or CHM were ¢rst
preincubated with HP which is transformed into a Michael
acceptor that is conjugated with mGSH [31,32]. HP depleted
mGSH levels to 20^30% of control values; the depleting po-
Fig. 2. E¡ect of Oc32 on the release of cyt c. Cyt c and cytochrome
oxidase (cyt ox.) were analyzed by Western blotting as described in
Section 2 in supernatants and mitochondria (a). In some cases, mi-
tochondria were preincubated with the antioxidant BHT (50 WM),
the VDAC inhibitor Ab#25 (0.5 Wg/Wl) or CSA (5 WM) before the
exposure to X+XO. The densitometric quantitation of cyt c release
under these conditions (b) is the meanUS.D. of four individual ex-
periments. *P6 0.05 versus control mitochondria or CHM treated
with X+XO.
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tential of HP was not a¡ected by mitochondrial cholesterol
content (Fig. 3a). While GD3 stimulated the formation of
hydrogen peroxide in control mitochondria, monitored by
the peroxide-sensitive £uorescence of DCF, this response
was hampered by cholesterol loading (Fig. 3b). However,
GSH depletion by HP further enhanced the generation of
hydrogen peroxide by GD3 in control mitochondria or
CHM compared to organelles not depleted of GSH although
the £uorescence of DCF was lower in CHM than in control
organelles (Fig. 3b). Moreover, to examine if the generation of
hydrogen peroxide by GD3 under these conditions of choles-
terol loading and GSH depletion was su⁄cient to induce
MPT, we next monitored mitochondrial swelling. As seen
(Fig. 3c), CHM did not show signi¢cant changes in A540nm
when exposed to GD3 in contrast to the outcome seen in
control mitochondria (Fig. 3c). However, when GSH was de-
pleted ¢rst by HP the loss of A540nm elicited by GD3 was
similar in both control mitochondria and CHM (Fig. 3c).
The preincubation with the antioxidant BHT prevented mito-
chondrial swelling induced by GD3 in GSH-depleted mito-
chondria in both control and cholesterol-enriched organelles
(Fig. 3c). Thus, the generation of hydrogen peroxide caused
by GD3 correlates with MPT, suggesting a threshold above
which hydrogen peroxide triggers MPT. Although GSH de-
pletion is required for GD3 to achieve this response the im-
pact of hydrogen peroxide on MPT is similar in control mi-
tochondria and CHM indicating that the inability of CHM to
undergo MPT in response to GD3 was due to the impaired
generation of reactive species.
Since our prior observations indicated that the function of
ANT as a MPT component is modulated by membrane £uid-
ity [29], we examined the role of mGSH on ATR-mediated
MPT (Fig. 3d). The depletion of mGSH did not modify the
ATR-induced MPT as determined by the osmotic swelling of
mitochondria nor the resistance seen in CHM (Fig. 3d). Fur-
thermore, consistent with these ¢ndings, HP pretreatment did
not a¡ect the release of cyt c, Smac/Diablo or AIF induced by
ATR (not shown). Finally, we examined the release of cyt c,
Smac/Diablo and AIF by GD3 with or without mGSH deple-
tion. As shown the data on osmotic swelling (Fig. 3c) paral-
Fig. 3. Regulation by mGSH of MPT induced by ATR or GD3. Control mitochondria (open bars) or CHM (closed bars) (1 mg/ml) were incu-
bated with 1 mM HP for 10 min at 37‡C and after thorough washing, GSH levels were determined as described in Section 2 (a). The time-de-
pendent generation of hydrogen peroxide was monitored from DCF £uorescence in the conditions shown (b). Control mitochondria or CHM
were exposed to GD3 (10 WM) (c) or ATR (100 WM) (d) with or without HP preincubation to examine the changes in A540nm. In some cases,
mitochondria were pretreated with BHT before HP treatment and GD3 or ATR. Results are the meanUS.D. of three individual experiments.
*P6 0.05 vs. control; #P6 0.05 vs. corresponding CHM.
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leled the release of apoptogenic factors caused by GD3 (Fig.
4). GD3 induced the release of cyt c, Smac/Diablo and AIF in
control mitochondria that was enhanced upon mGSH deple-
tion. However, in CHM, mGSH depletion was required for
GD3 to induce the release of these proteins (Fig. 4). Consis-
tent with the observations on mitochondrial swelling, BHT
prevented the release of these proteins in mGSH-depleted mi-
tochondria (not shown). In addition, the released proapop-
totic factors from mitochondria under mGSH depletion and
GD3 treatment resulted in the assembly of the apoptosome in
a cell-free system determined from the £uorescence of caspase-
3 substrates (not shown). Taken together these data highlight
the di¡erential role of mGSH in regulating MPT depending
on the stimuli used. ATR, a c-conformation ligand of ANT,
triggers MPT upon its binding to ANT. The ability of ATR to
induce MPT through ANT is regulated by mitochondrial
membrane dynamics [29]. The present observations indicate
that mGSH depletion per se does not alter the dependence
of ANT on appropriate membrane £uidity as CHM are resis-
tant to ATR-mediated MPT regardless of whether mGSH was
depleted or not. Moreover, although mGSH levels were con-
siderably depleted by HP to around 2 nmol/mg protein (Fig.
3a), the magnitude of depletion was insu⁄cient to stimulate
peroxide generation. In line with this, it was shown that only
when mGSH levels were depleted below 1 nmol/mg there was
enhanced generation of hydrogen peroxide induced by anti-
mycin A [40]. In contrast to these results with ANT, the
ability of GD3 to induce MPT is dependent on the mGSH
status. The combination of GD3 and mGSH depletion is
more e¡ective than GD3 alone to induce mitochondrial swell-
ing and release of apoptogenic proteins and, more impor-
tantly, CHM are rendered sensitive to GD3 upon mGSH
depletion (Fig. 3c). Therefore, the combination of mGSH de-
pletion and a ROS generating stimulus, e.g. GD3, promotes
apoptosome assembly independently of the cholesterol con-
tent of mitochondria.
The comparison of the ROS generation and impact on
MPT between X+XO and GD3 is of interest and provides
insight into the apparent resistance of CHM to GD3-induced
MPT. The pattern of ROS generation by X+XO or the com-
bination of GD3 plus HP agrees with the time-dependent
MPT changes observed in either case (Figs. 1 and 3). Further-
more, while X+XO generates ROS from outside mitochon-
dria, GD3 acts on the electron transport chain within mito-
chondria favoring the formation of hydrogen peroxide from
Mn-SOD-catalyzed dismutation of superoxide anion as char-
acterized previously [26,38]. Consistent with this di¡erent to-
pology of ROS generation cholesterol loading modulates the
generation of ROS by GD3 but not that caused by X+XO
(Figs. 1a and 3b). The level of hydrogen peroxide elicited by
GD3 in mitochondria with repleted GSH content re£ects the
stimulation of these species from the electron transport chain;
although this rate is hampered by cholesterol through a mech-
anism that would deserve further investigation in the future,
in conditions of GSH depletion hydrogen peroxide accumu-
lates to a higher level due to impaired function of the GSH
redox cycle of mitochondria [24,39]. Importantly, in this sce-
nario of GSH depletion hydrogen peroxide elicits MPT in
control mitochondria or CHM (Fig. 3c). Taken collectively,
the generation of ROS either extramitochondrially or within
mitochondria induces MPT independently of cholesterol load-
ing.
3.3. Concluding remarks
The present study shows the di¡erential e¡ect of cholesterol
deposition on the mitochondrial permeabilization, release of
apoptogenic factors and subsequent apoptosome activation.
Mitochondrial swelling and the inhibitory e¡ect of CSA are
characteristic features of MPT [2,11,12]. While cholesterol en-
richment impairs ANT-mediated MPT and release of mito-
chondrial proteins, CHM undergo swelling and release apop-
togenic proteins in response to stimuli that overproduce ROS
as illustrated with X+XO or the combination of mGSH de-
pletion and GD3 exposure. These ¢ndings may be of rele-
vance in the regulation of apoptotic pathways in conditions
of stimulated cholesterol deposition in mitochondria. For in-
stance, mitochondria from alcohol-fed rat liver or acetalde-
hyde-treated HepG2 cells have higher cholesterol levels and
defective transport of GSH into mitochondria [41^43]. In this
scenario alcohol intake would stimulate ganglioside biosyn-
thesis from sphingosine recycling, described recently in cere-
bellar granule cells cultured with ethanol [44], which in com-
bination with selective mGSH depletion would lead to
mitochondrial cell death, providing the basis for the sensitivity
of hepatocytes from alcohol-fed rats to tumor necrosis factor-
induced cell death [45,46].
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